These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 23786428)
1. Hypertension promotes islet morphological changes with vascular injury on pre-diabetic status in SHRsp rats. Satoh M; Nagasu H; Haruna Y; Ihoriya C; Kadoya H; Sasaki T; Kashihara N Clin Exp Hypertens; 2014; 36(3):159-64. PubMed ID: 23786428 [TBL] [Abstract][Full Text] [Related]
2. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Yamamoto E; Tamamaki N; Nakamura T; Kataoka K; Tokutomi Y; Dong YF; Fukuda M; Matsuba S; Ogawa H; Kim-Mitsuyama S Stroke; 2008 Nov; 39(11):3049-56. PubMed ID: 18688015 [TBL] [Abstract][Full Text] [Related]
3. Hypotensive and prophylactic effects of angiotensin II subtype 1 receptor antagonist, irbesartan, in stroke-prone spontaneously hypertensive rats. Shimamura T; Masui M; Torii M; Nakajima M Clin Exp Hypertens; 2004 Jan; 26(1):27-42. PubMed ID: 15000295 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of omapatrilat and irbesartan/hydrochlorothiazide on endothelial function and cardiac hypertrophy in the stroke-prone spontaneously hypertensive rat: sex differences. Graham D; Hamilton C; Beattie E; Spiers A; Dominiczak AF J Hypertens; 2004 Feb; 22(2):329-37. PubMed ID: 15076191 [TBL] [Abstract][Full Text] [Related]
5. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP. Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847 [TBL] [Abstract][Full Text] [Related]
6. Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF. Nako H; Kataoka K; Koibuchi N; Dong YF; Toyama K; Yamamoto E; Yasuda O; Ichijo H; Ogawa H; Kim-Mitsuyama S Hypertens Res; 2012 Feb; 35(2):194-200. PubMed ID: 22089532 [TBL] [Abstract][Full Text] [Related]
7. Olmesartan reduces oxidative stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method. Araki S; Hirooka Y; Kishi T; Yasukawa K; Utsumi H; Sunagawa K Hypertens Res; 2009 Dec; 32(12):1091-6. PubMed ID: 19763130 [TBL] [Abstract][Full Text] [Related]
8. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. Soltis EE J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197 [TBL] [Abstract][Full Text] [Related]
10. Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats. Nagayama T; Hirooka Y; Kishi T; Mukai Y; Inoue S; Takase S; Takemoto M; Chishaki A; Sunagawa K Am J Hypertens; 2015 Apr; 28(4):444-51. PubMed ID: 25352232 [TBL] [Abstract][Full Text] [Related]
11. Candesartan-induced gene expression in five organs of stroke-prone spontaneously hypertensive rats. Kato N; Liang YQ; Ochiai Y; Birukawa N; Serizawa M; Jesmin S Hypertens Res; 2008 Oct; 31(10):1963-75. PubMed ID: 19015604 [TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy. Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079 [TBL] [Abstract][Full Text] [Related]
15. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK; Dubinion JH; Mi Z Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [TBL] [Abstract][Full Text] [Related]
16. Establishment and use of the M strain of stroke-prone spontaneously hypertensive rat. Okamoto K; Yamamoto K; Morita N; Ohta Y; Chikugo T; Higashizawa T; Suzuki T J Hypertens Suppl; 1986 Oct; 4(3):S21-4. PubMed ID: 3465899 [TBL] [Abstract][Full Text] [Related]